Atea Pharmaceuticals (AVIR) Stock Chart & Stock Price History $3.49 +0.06 (+1.75%) Closing price 04:00 PM EasternExtended Trading$3.48 -0.01 (-0.14%) As of 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Atea Pharmaceuticals Stock Price Performance The Atea Pharmaceuticals (AVIR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 9.59%, with a year-to-date return of 4.18%. In the past month, the stock has increased 5.12%, reflecting recent market activity. As of the latest close, Atea Pharmaceuticals traded at $3.43 with a market cap of $293.54 million and volume of 383,566 shares. Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.87%1 Month Performance+5.12%3 Month Performance+22.46%Year-To-Date Performance+4.18%1 Year Performance-9.59% AVIR Stock Chart for Wednesday, July, 23, 2025 AVIR Chart by TradingView Atea Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/22/2025$3.43$3.43$3.49$3.42383,566 shs$293.54 million07/21/2025$3.36$3.43+2.08%$3.53$3.39394,963 shs$293.54 million07/18/2025$3.46$3.36-2.89%$3.52$3.36345,776 shs$287.55 million07/17/2025$3.49$3.46-0.86%$3.53$3.43388,027 shs$296.10 million07/16/2025$3.57$3.49-2.24%$3.74$3.46763,561 shs$298.67 million07/15/2025$3.76$3.57-5.05%$3.78$3.57335,838 shs$305.52 million07/14/2025$3.67$3.76+2.45%$3.79$3.66279,795 shs$321.78 million07/11/2025$3.78$3.67-2.91%$3.79$3.67311,695 shs$314.08 million07/10/2025$3.76$3.78+0.53%$3.83$3.75324,285 shs$323.49 million07/09/2025$3.65$3.76+3.01%$3.76$3.68378,725 shs$321.78 million Get the Latest News and Ratings for AVIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/08/2025$3.64$3.65+0.27%$3.76$3.65349,855 shs$312.37 million07/07/2025$3.67$3.64-0.82%$3.78$3.63424,024 shs$311.51 million07/04/2025$3.67$3.67$3.76$3.65286,948 shs$314.08 million07/03/2025$3.63$3.67+1.10%$3.76$3.65286,948 shs$314.08 million07/02/2025$3.60$3.63+0.83%$3.80$3.59493,063 shs$310.66 million07/01/2025$3.60$3.60$3.65$3.54390,565 shs$308.09 million06/30/2025$3.45$3.60+4.35%$3.73$3.45642,946 shs$308.09 million06/27/2025$3.53$3.45-2.27%$3.60$3.43444,473 shs$295.25 million06/26/2025$3.47$3.53+1.73%$3.62$3.49449,799 shs$302.10 million06/25/2025$3.38$3.47+2.66%$3.51$3.35354,180 shs$296.96 million06/24/2025$3.32$3.38+1.81%$3.45$3.33515,953 shs$289.26 million06/23/2025$3.25$3.32+2.15%$3.37$3.23365,271 shs$284.13 million Related Companies Enliven Therapeutics Stock Price Chart Structure Therapeutics Stock Price Chart BGM Group Stock Price Chart Praxis Precision Medicines Stock Price Chart Ardelyx Stock Price Chart Avadel Pharmaceuticals Stock Price Chart Sana Biotechnology Stock Price Chart Dyne Therapeutics Stock Price Chart Akebia Therapeutics Stock Price Chart Collegium Pharmaceutical Stock Price Chart Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVIR) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
